Market Research Logo

Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENS), By End-User (Biotech and Pharma Companies, Contract Research Organiz

Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENS), By End-User (Biotech and Pharma Companies, Contract Research Organization (CRO), Research Institutes) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, Poland, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Gene Editing Market will exceed USD 7.5 billion by 2024; as per a new research report.

Rising prevalence of cancer and other genetic disorders coupled with increasing demand for personalized medicine should stimulate gene editing industry expansion. As per WHO 2018 report, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths. Increasing use of the gene editing tools for treatment of these chronic disorders will favor business growth. Moreover, increased government funding programs will significantly impact industry growth over the forecast timeframe.

Many biopharmaceutical companies are focused on developing innovative drugs for various genetic disorders because of high disease burden across the world and their considerable market potential. Other parameters contributing to the industry growth are increasing demand for synthetic genes, extensive investments in R&D, technological advancements in the field of molecular biology. However, ethical issues regarding misuse of genome editing is a major concern and may hamper the industry growth.

Animal genetic engineering segment was valued at USD 785.4 million in 2017 and is projected to grow significantly over the forecast timeframe. Growing applications of products obtained from domestic animals has boosted the demand for gene editing technique. In addition, wide applicability of these techniques in animal genetic engineering is also a contributing factor for business growth. For instance, Pigs are susceptible to an infection called Porcine Reproductive and Respiratory Syndrome (PRRS). Gene editing techniques have managed to produce pigs that are resistance to this disease.

Zinc Finger Nucleases (ZFNs) segment will witness 14.5% CAGR from 2018 to 2024. The segment growth is attributed to increasing adoption of these advanced gene editing tools in research institutes and biotech industries. ZFNs technology offers various advantages including, the mutations made by this technology are permeant and heritable. Zinc finger nucleases are useful to manipulate the genomes of many plants and animals and also has important role in gene editing processes.

Research institutes segment accounted for 30.2% revenue share in 2017 owing to increasing focus on developing innovative therapeutics models in CRISPR and ZFN. Moreover, growing incidences of rare genetic diseases has resulted in high demand for research activities for developing new therapies will propel segmental growth over the coming years.

U.S. gene editing market will witness 14.5% CAGR by 2024 owing to increasing funding for research and development in genetic editing technologies. As per National Center for Advancing Translational Sciences 2018 report, National Institute of Health (NIH) got $86 million funding for improving genome editing techniques. Moreover, rising prevalence of Alzheimer, cancer and infectious diseases in country. As per Alzheimer’s association 2018 report, an estimated 5.7 million Americans of all ages are living with Alzheimer's. Increasing patient preference towards advanced gene editing tools such as CRISPR/Cas9 for the treatment of Alzheimer's should drive gene editing business expansion.

China gene editing market was valued at USD 154.6 million in 2017 and is estimated to experience considerable growth due to rising R&D expenditure and growing number of industry players. Moreover, various initiatives taken by the Chinese government for promoting life science research in biotechnology sector will stimulate gene editing market growth in forthcoming years.

Some of the prominent competitors operating in gene editing market include Addgene, Allele Biotech, Bio-Rad, Takara Bio, CRISPR Therapeutics, DNA 2.0, Editas Medicine, Intellia Therapeutics, Integrated DNA Technologies, Juno Therapeutics, OriGene Technologies, Promega, Precision Biosciences and Recombinetics. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions to escalate their market position as well as strengthen product offerings.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Gene editing industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Technology trends
2.1.4. End-user trends
2.1.5. Regional trends
Chapter 3. Gene Editing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increased funding for genetic research in North America
3.3.1.2. Increased R&D expenditure and growth of biotechnology sector in Europe
3.3.1.3. Increasing demand for synthetic genes in Asia Pacific and North America
3.3.1.4. Technological advancements in gene editing in North America
3.3.2. Industry pitfalls and challenges
3.3.2.1. Stringent government regulations
3.3.2.2. Lack of public awareness in developing and underdeveloped regions
3.4. Growth potential analysis
3.4.1. By application
3.4.2. By technology
3.4.3. By end-user
3.5. Competitive landscape, 2017
3.5.1. Strategy dashboard
3.6. Porter's analysis
3.7. PESTEL analysis
Chapter 4. Gene Editing Market, By Application
4.1. Key segment trends
4.2. Cell line engineering
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.3. Animal genetic engineering
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.4. Plant genetic engineering
4.4.1. Market size, by region, 2013-2024 (USD Million)
4.5. Other applications
4.5.1. Market size, by region, 2013-2024 (USD Million)
Chapter 5. Gene Editing Market, By Technology
5.1. Key segment trends
5.2. CRISPR/Cas9
5.2.1. Market size, by region, 2013-2024 (USD Million)
5.3. Zinc Finger Nucleases (ZFNs)
5.3.1. Market size, by region, 2013-2024 (USD Million)
5.4. TALENS
5.4.1. Market size, by region, 2013-2024 (USD Million)
5.5. Others
5.5.1. Market size, by region, 2013-2024 (USD Million)
Chapter 6. Gene Editing Market, By End-User</B>
6.1. Key segment trends
6.2. Biotech and Pharma Companies
6.2.1. Market size, by region, 2013-2024 (USD Million)
6.3. Contract Research Organization (CRO)
6.3.1. Market size, by region, 2013-2024 (USD Million)
6.4. Research Institutes
6.4.1. Market size, by region, 2013-2024 (USD Million)
Chapter 7. Gene Editing Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country, 2013 - 2024 (USD Million)
7.2.2. Market size, by application, 2013 - 2024 (USD Million)
7.2.3. Market size, by technology, 2013 - 2024 (USD Million)
7.2.4. Market size, by end-user, 2013 - 2024 (USD Million)
7.2.5. U.S.
7.2.5.1. Market size, by application, 2013 - 2024 (USD Million)
7.2.5.2. Market size, by technology, 2013 - 2024 (USD Million)
7.2.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.2.6. Canada
7.2.6.1. Market size, by application, 2013 - 2024 (USD Million)
7.2.6.2. Market size, by technology, 2013 - 2024 (USD Million)
7.2.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3. Europe
7.3.1. Market size, by country, 2013 - 2024 (USD Million)
7.3.2. Market size, by application, 2013 - 2024 (USD Million)
7.3.3. Market size, by technology, 2013 - 2024 (USD Million)
7.3.4. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.5. Germany
7.3.5.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.5.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.6. France
7.3.6.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.6.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.7. UK
7.3.7.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.7.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.7.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.8. Italy
7.3.8.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.8.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.8.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.9. Spain
7.3.9.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.9.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.9.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.10. Russia
7.3.10.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.10.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.10.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.3.11. Poland
7.3.11.1. Market size, by application, 2013 - 2024 (USD Million)
7.3.11.2. Market size, by technology, 2013 - 2024 (USD Million)
7.3.11.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.4. Asia Pacific
7.4.1. Market size, by country, 2013 - 2024 (USD Million)
7.4.2. Market size, by application, 2013 - 2024 (USD Million)
7.4.3. Market size, by technology, 2013 - 2024 (USD Million)
7.4.4. Market size, by end-user, 2013 - 2024 (USD Million)
7.4.5. China
7.4.5.1. Market size, by application, 2013 - 2024 (USD Million)
7.4.5.2. Market size, by technology, 2013 - 2024 (USD Million)
7.4.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.4.6. Japan
7.4.6.1. Market size, by application, 2013 - 2024 (USD Million)
7.4.6.2. Market size, by technology, 2013 - 2024 (USD Million)
7.4.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.4.7. India
7.4.7.1. Market size, by application, 2013 - 2024 (USD Million)
7.4.7.2. Market size, by technology, 2013 - 2024 (USD Million)
7.4.7.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.4.8. South Korea
7.4.8.1. Market size, by application, 2013 - 2024 (USD Million)
7.4.8.2. Market size, by technology, 2013 - 2024 (USD Million)
7.4.8.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.4.9. Australia
7.4.9.1. Market size, by application, 2013 - 2024 (USD Million)
7.4.9.2. Market size, by technology, 2013 - 2024 (USD Million)
7.4.9.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.5. Latin America
7.5.1. Market size, by country, 2013 - 2024 (USD Million)
7.5.2. Market size, by application, 2013 - 2024 (USD Million)
7.5.3. Market size, by technology, 2013 - 2024 (USD Million)
7.5.4. Market size, by end-user, 2013 - 2024 (USD Million)
7.5.5. Brazil
7.5.5.1. Market size, by application, 2013 - 2024 (USD Million)
7.5.5.2. Market size, by technology, 2013 - 2024 (USD Million)
7.5.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.5.6. Mexico
7.5.6.1. Market size, by application, 2013 - 2024 (USD Million)
7.5.6.2. Market size, by technology, 2013 - 2024 (USD Million)
7.5.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.5.7. Argentina
7.5.7.1. Market size, by application, 2013 - 2024 (USD Million)
7.5.7.2. Market size, by technology, 2013 - 2024 (USD Million)
7.5.7.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.6. MEA
7.6.1. Market size, by country, 2013 - 2024 (USD Million)
7.6.2. Market size, by application, 2013 - 2024 (USD Million)
7.6.3. Market size, by technology, 2013 - 2024 (USD Million)
7.6.4. Market size, by end-user, 2013 - 2024 (USD Million)
7.6.5. South Africa
7.6.5.1. Market size, by application, 2013 - 2024 (USD Million)
7.6.5.2. Market size, by technology, 2013 - 2024 (USD Million)
7.6.5.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.6.6. Saudi Arabia
7.6.6.1. Market size, by application, 2013 - 2024 (USD Million)
7.6.6.2. Market size, by technology, 2013 - 2024 (USD Million)
7.6.6.3. Market size, by end-user, 2013 - 2024 (USD Million)
7.6.7. UAE
7.6.7.1. Market size, by application, 2013 - 2024 (USD Million)
7.6.7.2. Market size, by technology, 2013 - 2024 (USD Million)
7.6.7.3. Market size, by end-user, 2013 - 2024 (USD Million)
Chapter 8. Company Profiles
8.1. Addgene
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Allele Biotech
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Bio-Rad
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Takara Bio
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. CRISPR Therapeutics
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. DNA2.0
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Integrated DNA Technologies
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. OriGene Technologies
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Precision Biosciences
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. GE Healthcare Dharmacon Inc.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. GeneCopoeia, Inc.
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. GenScript Corporation
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
8.13. Horizon Discovery Group plc
8.13.1. Business overview
8.13.2. Financial data
8.13.3. Product landscape
8.13.4. Strategic outlook
8.13.5. SWOT analysis
8.14. Merck Millipore Limited
8.14.1. Business overview
8.14.2. Financial data
8.14.3. Product landscape
8.14.4. Strategic outlook
8.14.5. SWOT analysis
8.15. Sangamo Biosciences, Inc.
8.15.1. Business overview
8.15.2. Financial data
8.15.3. Product landscape
8.15.4. Strategic outlook
8.15.5. SWOT analysis
8.16. Agilent Technologies, Inc.
8.16.1. Business overview
8.16.2. Financial data
8.16.3. Product landscape
8.16.4. Strategic outlook
8.16.5. SWOT analysis
8.17. Thermo Fisher Scientific
8.17.1. Business overview
8.17.2. Financial data
8.17.3. Product landscape
8.17.4. Strategic outlook
8.17.5. SWOT analysis
8.18. Caribou Biosciences, Inc.
8.18.1. Business overview
8.18.2. Financial data
8.18.3. Product landscape
8.18.4. Strategic outlook
8.18.5. SWOT analysis
Data Tables/B>
TABLE 1. Gene editing industry 360 degree synopsis, 2013 - 2024
TABLE 2. Gene editing market, 2013-2017 (USD Mn)
TABLE 3. Gene editing market, 2018-2024 (USD Mn)
TABLE 4. Gene editing market, by application, 2013-2024 (USD Mn)
TABLE 5. Gene editing market, by technology, 2013-2024 (USD Mn)
TABLE 6. Gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 7. Gene editing market, by region, 2013-2024 (USD Mn)
TABLE 8. Industry impact forces
TABLE 9. Cell Line Engineering market size, by region, 2013-2024 (USD Mn)
TABLE 10. Animal Genetic Engineering market size, by region, 2013-2024 (USD Mn)
TABLE 11. Plant Genetic Engineering market size, by region, 2013-2024 (USD Mn)
TABLE 12. Other Applications market size, by region, 2013-2024 (USD Mn)
TABLE 13. North America gene editing market size, by country, 2013-2024 (USD Mn)
TABLE 14. North America gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 15. North America gene editing market size, by technology, 2013-2017 (USD Mn)
TABLE 16. North America gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 17. U.S. gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 18. U.S. Gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 19. U.S. Gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 20. Canada gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 21. Canada Gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 22. Canada Gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 23. Europe gene editing market size, by country, 2013-2024 (USD Mn)
TABLE 24. Europe gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 25. Europe gene editing market size, by technology, 2013-2017 (USD Mn)
TABLE 26. Europe gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 27. Germany gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 28. Germany gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 29. Germany gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 30. UK gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 31. UK gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 32. UK gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 33. France gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 34. France gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 35. France gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 36. Spain gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 37. Spain gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 38. Spain gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 39. Italy gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 40. Italy gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 41. Italy gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 42. Russia gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 43. Russia gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 44. Russia gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 45. Poland gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 46. Poland gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 47. Poland gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 48. Asia Pacific gene editing market size, by country, 2013-2024 (USD Mn)
TABLE 49. Asia Pacific gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 50. Asia Pacific gene editing market size, by technology, 2013-2017 (USD Mn)
TABLE 51. Asia Pacific gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 52. Japan gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 53. Japan gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 54. Japan gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 55. China gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 56. China gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 57. China gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 58. India gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 59. India gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 60. India gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 61. South Korea gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 62. South Korea gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 63. South Korea gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 64. Australia gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 65. Australia gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 66. Australia gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 67. Latin America gene editing market size, by country, 2013-2024 (USD Mn)
TABLE 68. Latin America gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 69. Latin America gene editing market size, by technology, 2013-2017 (USD Mn)
TABLE 70. Latin America gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 71. Brazil gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 72. Brazil gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 73. Brazil gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 74. Mexico gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 75. Mexico gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 76. Mexico gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 77. Argentina gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 78. Argentina gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 79. Argentina gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 80. MEA gene editing market size, by country, 2013-2024 (USD Mn)
TABLE 81. MEA Pacific gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 82. MEA gene editing market size, by technology, 2013-2017 (USD Mn)
TABLE 83. MEA gene editing market, by end-user, 2013-2024 (USD Mn)
TABLE 84. South Africa gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 85. South Africa gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 86. South Africa gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 87. Saudi Arabia gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 88. Saudi Arabia gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 89. Saudi Arabia gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 90. South Africa gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 91. South Africa gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 92. South Africa gene editing market size, by end-user, 2013-2024 (USD Mn)
TABLE 93. UAE gene editing market size, by application, 2013-2024 (USD Mn)
TABLE 94. UAE gene editing market size, by technology, 2013-2024 (USD Mn)
TABLE 95. UAE gene editing market size, by end-user, 2013-2024 (USD Mn)
Charts & Figures
FIG 1. Industry segmentation
FIG 2. Global Gene editing market, 2013 - 2024 (USD Mn)
FIG 3. Growth potential analysis, by application
FIG 4. Growth potential analysis, by technology
FIG 5. Growth potential analysis, by end-user
FIG 6. Porter's analysis
FIG 7. Strategy dashboard
FIG 8. PESTEL analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook